Advertisement
Research Article Free access | 10.1172/JCI102299
The Department of Medicine of the University of Chicago
1Read at the Fortieth Annual Meeting of the American Society for Clinical Investigation, May 3, 1948, and at the Thirtieth Annual Meeting of the Association for the Study of Internal Secretions, June 18 and 19, 1948.
2This work was supported by a grant from the American Cancer Society on recommendation by the Committee on Growth. It was also aided by a grant from the Douglas Smith Foundation for Medical Research (R. L. Landau).
3We are indebted to Ayerst, McKenna and Harrison (E. C. Reifenstein, Jr.) and to Squibb and Sons (Robert Bates) for the chorionic gonadotropin, and to the Schering Corp. (E. Henderson) for the testosterone propionate used in these studies.
Find articles by Landau, R. in: PubMed | Google Scholar
The Department of Medicine of the University of Chicago
1Read at the Fortieth Annual Meeting of the American Society for Clinical Investigation, May 3, 1948, and at the Thirtieth Annual Meeting of the Association for the Study of Internal Secretions, June 18 and 19, 1948.
2This work was supported by a grant from the American Cancer Society on recommendation by the Committee on Growth. It was also aided by a grant from the Douglas Smith Foundation for Medical Research (R. L. Landau).
3We are indebted to Ayerst, McKenna and Harrison (E. C. Reifenstein, Jr.) and to Squibb and Sons (Robert Bates) for the chorionic gonadotropin, and to the Schering Corp. (E. Henderson) for the testosterone propionate used in these studies.
Find articles by Knowlton, K. in: PubMed | Google Scholar
The Department of Medicine of the University of Chicago
1Read at the Fortieth Annual Meeting of the American Society for Clinical Investigation, May 3, 1948, and at the Thirtieth Annual Meeting of the Association for the Study of Internal Secretions, June 18 and 19, 1948.
2This work was supported by a grant from the American Cancer Society on recommendation by the Committee on Growth. It was also aided by a grant from the Douglas Smith Foundation for Medical Research (R. L. Landau).
3We are indebted to Ayerst, McKenna and Harrison (E. C. Reifenstein, Jr.) and to Squibb and Sons (Robert Bates) for the chorionic gonadotropin, and to the Schering Corp. (E. Henderson) for the testosterone propionate used in these studies.
Find articles by Lugibihl, K. in: PubMed | Google Scholar
The Department of Medicine of the University of Chicago
1Read at the Fortieth Annual Meeting of the American Society for Clinical Investigation, May 3, 1948, and at the Thirtieth Annual Meeting of the Association for the Study of Internal Secretions, June 18 and 19, 1948.
2This work was supported by a grant from the American Cancer Society on recommendation by the Committee on Growth. It was also aided by a grant from the Douglas Smith Foundation for Medical Research (R. L. Landau).
3We are indebted to Ayerst, McKenna and Harrison (E. C. Reifenstein, Jr.) and to Squibb and Sons (Robert Bates) for the chorionic gonadotropin, and to the Schering Corp. (E. Henderson) for the testosterone propionate used in these studies.
Find articles by Brandt, M. in: PubMed | Google Scholar
The Department of Medicine of the University of Chicago
1Read at the Fortieth Annual Meeting of the American Society for Clinical Investigation, May 3, 1948, and at the Thirtieth Annual Meeting of the Association for the Study of Internal Secretions, June 18 and 19, 1948.
2This work was supported by a grant from the American Cancer Society on recommendation by the Committee on Growth. It was also aided by a grant from the Douglas Smith Foundation for Medical Research (R. L. Landau).
3We are indebted to Ayerst, McKenna and Harrison (E. C. Reifenstein, Jr.) and to Squibb and Sons (Robert Bates) for the chorionic gonadotropin, and to the Schering Corp. (E. Henderson) for the testosterone propionate used in these studies.
Find articles by Kenyon, A. in: PubMed | Google Scholar
Published May 1, 1950 - More info